Corneal Cross-Linking-Induced Stromal Demarcation Line

Purpose: Corneal collagen cross-linking by UVA/riboflavin (X-linking) represents a new method for the treatment of progressive keratoconus and currently is under clinical study. To avoid UVA irradiation damage to the corneal endothelium, the parameters for X-linking are set in a way that effective treatment occurs only in the first 300 μm of the corneal stroma. Here, X-linking not only strengthens the biomechanical properties of the cornea but also induces keratocyte apoptosis. To date, the effectiveness of treatment could be monitored only indirectly by postoperative follow-up corneal topographies or using corneal confocal microscopy. Here we describe a corneal stromal demarcation line indicating the transition zone between cross-linked anterior corneal stroma and untreated posterior corneal stroma. The demarcation line is biomicroscopically detectable in slit-lamp examination as early as 2 weeks after treatment. Methods: X-linking was performed in 16 cases of progressive keratoconus, and corneas were examined biomicroscopically and by means of corneal topography and pachymetry before and after treatment. Results: In 14 of 16 cases, a thin stromal demarcation line was visible at a depth of approximately 300 μm over the whole cornea after X-linking treatment. Conclusion: This newly observed demarcation line may result from differences in the refractive index and/or reflection properties of untreated versus X-linked corneal stroma and represents an effective tool to biomicroscopically easily monitor the depth of effective X-linking treatment in keratoconus.

[1]  T. Seiler,et al.  [Treatment of keratoconus by collagen cross linking]. , 2003, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

[2]  S. Wilson,et al.  Role of apoptosis in wound healing in the cornea. , 2000, Cornea.

[3]  E. Spoerl,et al.  Induction of cross-links in corneal tissue. , 1998, Experimental eye research.

[4]  M. Kasper,et al.  [Increased rigidity of the cornea caused by intrastromal cross-linking]. , 1997, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

[5]  Claudio Traversi,et al.  Parasurgical therapy for keratoconus by riboflavin–ultraviolet type A rays induced cross‐linking of corneal collagen: Preliminary refractive results in an Italian study , 2006, Journal of cataract and refractive surgery.

[6]  Theo Seiler,et al.  Keratocyte Apoptosis After Corneal Collagen Cross-linking Using Riboflavin/UVA Treatment , 2004, Cornea.

[7]  E. Spörl,et al.  Untersuchungen zur Verfestigung der Hornhaut am Kaninchen , 2000, Der Ophthalmologe.

[8]  T. Seiler,et al.  Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. , 2003, American journal of ophthalmology.

[9]  T. Seiler,et al.  Stress‐strain measurements of human and porcine corneas after riboflavin–ultraviolet‐A‐induced cross‐linking , 2003, Journal of cataract and refractive surgery.

[10]  J. Schwiegerling,et al.  Keratoconus Detection Based on Videokeratoscopic Height Data , 1996, Optometry and vision science : official publication of the American Academy of Optometry.

[11]  G. Wollensak,et al.  Behandlung von Keratokonus durch Kollagenvernetzung , 2003, Der Ophthalmologe.

[12]  T. Seiler,et al.  Endothelial cell damage after riboflavin–ultraviolet‐A treatment in the rabbit , 2003, Journal of cataract and refractive surgery.

[13]  T. Seiler,et al.  [Studies on the stabilization of the cornea in rabbits]. , 2000, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

[14]  T. Seiler,et al.  Techniques for stiffening the cornea. , 1999, Journal of refractive surgery.

[15]  G. Wollensak,et al.  Corneal Endothelial Cytotoxicity of Riboflavin/UVA Treatment in vitro , 2003, Ophthalmic Research.